Skin substitutes: An overview

Annals of the College of Surgeons of Hong Kong

Volumn 6, Issue 4, 2002, Pages 102-108

  Ho, Wai Sun ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 6 SULFATE; COLLAGEN TYPE 4; FIBRONECTIN; GLYCOSAMINOGLYCAN;

BURN; CELL STRAIN 3T3; COMPOSITE SKIN GRAFT; DIABETIC FOOT; EPIDERMOLYSIS BULLOSA DYSTROPHICA; ESTHETIC SURGERY; FULL THICKNESS SKIN GRAFT; HUMAN; KELOID; KERATINOCYTE; LEG ULCER; PLASTIC SURGERY; REVIEW; SKIN AUTOGRAFT; SKIN CULTURE; SKIN GRAFT; SKIN INJURY; SPLIT THICKNESS SKIN GRAFT; TISSUE ENGINEERING; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

EID: 0036865252     PISSN: 10284001     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2034.2002.00150.x     Document Type: Review

References (79)

1. Rushmer RF, Buettner KJ, Short JM, Odland GF. The skin. Science 1966; 154: 343-8.
2. Holbrook KA, Odland GF. Regional differences in the thickness (cell layers) of the human stratum corneum: An ultrastructural analysis. J. Invest. Dermatol. 1974; 62: 415-22.
3. Meehan M. Multisite pressure ulcer prevalence survey. Decubitus 1990; 3: 14-17.
4. Boyce ST. Cultured skin for wound closure. In: Rouabhia M, ed. Skin Substitute Production by Tissue Engineering: Clinical and Fundamental Applications. Texas: RG Landers, 1997; 75-102.
5. Breast JH. The Edwin Smith Surgical Papyrus. Chicago: University of Chicago, 1930.
6. Richards DW. Hopprocrates of Ostia. JAMA 1968; 204: 1049-56.
7. Ren X. The formation and development of the Chinese traditional surgical treatment. Chin. J. Med. Hist. 1988; 18: 81-5.
8. Fu XB. Wound healing research in China. Wound Report Reg. 1995; 3: 237-8.
9. Fu XB, Wang ZG, Sheng ZY. Advances in wound healing research in China: From antiquity to the present. Wound Report Reg. 2001; 9: 2-10.
10. Fu XB. History of wound healing and tissue regeneration. In: Fu XB, Wang DW, eds. Modern Wound Healing. Beijing: Military Surgeon Press, 1999; 1-16.
11. Liu GQ, Wang ZX. Achievements of critical care medicines in handbook of prescription for emergency (Zhou Hou Fan). Chin. J. Med. Hist. 1983; 13: 199-203.
12. Yan JM. The theory and treatment principle of carbunculosis in Qin-Han period. Chin. J. Med. Hist. 1998; 28: 26-8.
13. Winter RD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-4.
14. Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200: 377-9.
15. Alvarez OM, Mertz PM, Eaglestein WH. The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds. J. Surg. Res. 1983; 35: 142-8.
16. Caldwell Jr FT, Bowser BH, Crabtree JH. The effect of occlusive dressings on the energy metabolism of severely burned children. Ann. Surg. 1981; 193: 579-91.
17. Barnett A, Berkowitz RL, Mills R, Vistnes LM. Comparison of synthetic adhesive moisture vapor permeable and fine mesh gauze dressings for split-thickness skin graft donor sites. Am. J. Surg. 1983; 145: 379-81.
18. Balasubramani M, Kumar TR, Babu M. Skin substitutes: A review. Burns 2001; 27: 534-44.
19. Earle W, Brian J, Schellinge E. Certain factors limiting the size of the tissue culture and the development of massive culture. Ann. NY Acad. Sci. 1954; 58: 1000-11.
20. Basset C, Evans V, Earle W. Characteristics and potentials of long term culture of human skin. Plast. Reconstr. Surg. 1956; 17: 421-9.
21. Puck T. Clonal growth of mammalian cells in vitro: Growth characteristics of colonies from single HeLa cells with a 'Feeder Layer'. J. Exp. Med. 1956; 103: 273-83.
22. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 1975; 6: 331-43.
23. O'Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981; 1: 75-8.
24. Gallico GG, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Engl. J. Med. 1984; 311: 448-51.
25. Cuono C, Langdon R, McGuire J. Use of cultured autografts and dermal allografts as skin replacement after burn injury. Lancet 1986; 1: 1123-4.
26. Eldad A, Burt A, Clarke JA, Gusterson B. Cultured epithelium as a skin substitute. Burns 1987; 13: 173-80.
27. Herzog SR, Meyer A, Woodley D, Peterson HD. Wound coverage with cultured autologous keratinocytes: Use after burn wound excision including biopsy follow up. J. Trauma 1988; 28: 195-8.
28. Munster AM, Weiner SH, Spence RJ. Cultured epidermis for the coverage of massive burn wounds: A single center experience. Ann. Surg. 1990; 211: 676-80.
29. Hefton JM, Caldwell D, Biozes DG, Balin AK, Carter DM. Grafting of skin ulcers with cultured autologous epidermal cells. J. Am. Acad. Dermatol. 1986; 14: 399-405.
30. Carter DM, Lin AN, Varghese MC, Caldwell D, Pratt LA, Eisinger M. Treatment of junctional epidermolysis bullosa with epidermal autografts. J. Am. Acad. Dermatol. 1987; 17: 246-50.
31. Gallico GG, O'Connor NE, Compton CC, Remensnyder JP, Kehinde O, Green H. Cultured epithelial autografts for giant congenital nevi. Plast. Reconstr. Surg. 1989; 84: 1-9.
32. De Luca M, Bondanza S, Cancedda R et al. Permanent coverage of full skin thickness burns with autologous cultured epidermis and re-epithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: A multicentre study in the treatment of children. Burns 1992; 18 (Suppl.): S16-19.
33. Myers S, Navsaria H, Sanders R, Green C, Leigh I. Transplantation of kerationcytes in the treatment of wounds. Am. J. Surg. 1995; 170: 75-83.
34. McGrath JA, Schofield MV, Yamamoto AI et al. Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa. J. Am. Acad. Dermatol. 1993; 29: 407-19.
35. Gilchrest BA. In vitro assessment of keratinocyte aging. J. Invest. Dermatol. 1983; 81 (Suppl.): S184-9.
36. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br. J. Dermatol. 1987; 117: 591-7.
37. Phillips TJ, Kehinde O, Green H, Gilchrest B. Treatment of skin ulcers with cultured epidermal allografts. J. Am. Acad. Dermatol. 1989; 21: 191-9.
38. De Luca M, Albanese E, Cancedda R et al. Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium: A multicenter study. Arch. Dermatol. 1992; 128: 633-8.
39. Burd A, Chan E. Keratinocyte-keloid interaction. Plast. Reconstr. Surg. 2002; 110: 197-202.
40. Odessey R. Multicenter experience with cultured epidermal autograft of burns. J. Burn Care Rehabil. 1992; 13: 174-80.
41. Myers SR, Grady J, Soranzo C et al. A hyaluronic acid membrane delivery system for cultured keratinocytes: Clinical 'take' rates in the porcine kerato-dermal model. J. Burn Care Rehabil. 1997; 18: 214-22.
42. Lam PK, Chan ES, To EW, Lau CH, Yen SC, King WW. Development and evaluation of a new composite Laserskin graft. J. Trauma 1999; 47: 918-22.
43. Lam PK, Chan ES, Liew CT, Lau C, Yen SC, King WW. Combination of a new composite biocompatible skin graft on the neodermis of artificial skin in an animal model. Aust. NZ J. Surg, 2002; 72: 360-3.
44. Chan ES, Lam PK, Liew CT, Yen RS, Lau JW. The use of composite biodegradable skin graft and artificial skin for burn reconstruction. Plast. Reconstr. Surg. 2000; 105: 807-8.
45. Chan ES, Lam PK, Liew CT, Lau HC, Yen RS, King WW. A new technique to resurface wounds with composite biocompatible epidermal graft and artificial skin. J. Trauma 2001; 50: 358-62.
46. Burd A, Young R, Poon V. Tissue engineering: A shifting paradigm. Burns 2002; 28: 285-6.
47. Phillips TJ. Cultured skin grafts: Past, present, future. Arch. Dermatol. 1988; 124: 1035-8.
48. Phillips TJ, Gilchrest BA. Clinical applications of cultured epithelium. Epithelial Cell Biol. 1992; 1: 38-9.
49. Sheridan RL, Tompkins RG. Skin substitutes in burns. Burns 1999; 25: 97-103.
50. Cuono C, Langdon R, Birchall N, Barttelbort S, McGuire J. Composite autologous-allogeneic skin replacement: Development and clinical application. Plast. Reconstr. Surg. 1987; 80: 626-35.
51. Woodley DT, Peterson HD, Herzog SR et al. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA 1988; 259: 2566-71.
52. Petersen MJ, Lessane B, Woodley DT. Characterization of cellular elements in healed cultured keratinocyte autografts used to cover burn wounds. Arch. Dermatol. 1990; 126: 175-80.
53. Heck El Bergstrasser PR, Baxter CR. Composite skin graft: Frozen dermal allografts support the engraftment and expansion of autologous epidermis. J. Trauma 1985; 25: 106-12.
54. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995; 21: 243-8.
55. Wainwright D, Madden M, Luterman A et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J. Burn Care Rehabil. 1996; 17: 124-36.
56. Erol OO. AlloDerm used in rhinoplasty. Plast. Reconstr. Surg. 2001; 108: 1827-8.
57. Gryskiewicz JM, Rohrich RJ, Reagan BJ. The use of Alloderm for the correction of nasal contour deformities. Plast. Reconstr. Surg. 2001; 107: 561-70.
58. Gryskiewicz JM. Alloderm lip augmentation. Plast. Reconstr. Surg. 2000; 106: 953-4.
59. Costantino PD, Wolpoe ME, Govindaraj S et al. Human dural replacement with acellular dermis: Clinical results and a review of the literature. Head Neck-J. Sci. Spec. 2001; 22: 765-71.
60. Warren WL, Medary MB, Dureza CD et al. Dural repair using acellular human dermis: Experience with 200 cases. Technique assessment. Neurosurgery 2000; 46: 1391-6.
61. Govindaraj S, Cohen M, Genden EM, Costantino PD, Urken ML. The use of acellular dermis in the prevention of Frey's syndrome. Laryngoscope 2001; 111: 1993-8.
62. Rubin PA, Fay AM, Remulla HD, Maus M. Ophthalmic plastic applications of acellular dermal allografts. Ophthalmology 1999; 106: 2091-7.
63. Yannas IV, Burke JF. Design of an artificial skin. I: Basic design principles. J. Biomed. Mater. Res. 1980; 14: 65-81.
64. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II: Control of chemical composition. J. Biomed. Mater. Res. 1980; 14: 107-32.
65. Burke JF, Yannas IV, Quinbu WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann. Surg. 1981; 194: 413-28.
66. Heimbach D, Luterman A, Burke J et al. Artificial dermis for major burns: A multi-center randomized clinical trial. Ann. Surg. 1988; 208: 313-20.
67. Sheridan RL, Tompkins RG, Burke JF. Artificial skin in massive burns: Results to ten years. Eur. J. Plast. Surg. 1994; 17: 91-3.
68. Laning JC, DeLuca JE, Hardin-Young J. Effects of immunoregulatory cytokines on the immunogenic potential of the cellular components of a bilayered living skin equivalent. Tiss. Eng. 1999; 5: 171-81.
69. Eaglstein WH, Alvarez OM, Auletta M et al. Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol. Surg. 1999; 25: 195-201.
70. Brem H, Balledux J, Sukkarieh T, Carson P, Falanga V. Healing of venous ulcers of long duration with a bilayered living skin substitute: Results from a general surgery and dermatology department. Dermatol. Surg. 2001; 27: 915-19.
71. Brem H, Balledux J, Bloom T, Kerstein MD, Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing. Arch. Surg. 2000; 135: 627-34.
72. Muhart M, McFalls S, Kirsner RS et al. Behavior of tissue-engineered skin: A comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch. Dermatol. 1999; 135: 913-18.
73. Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch. Dermatol. 2000; 136: 1225-30.
74. Falanga V, Sabolinski M. A bilayered living skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999; 7: 201-7.
75. Falanga V, Margolis D, Alvarez O et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch. Dermatol. 1998; 134: 293-300.
76. Schonfeld WH, Villa KF, Fastenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen. 2000; 8: 251-7.
77. Mathias SD, Prebil LA, Boyko WL, Fastenau J. Health-related quality of life in venous leg ulcer patients successfully treated with Apligraf: A pilot study. Adv. Skin Wound Care 2000; 13: 76-8.
78. Shakespeare P. Skin substitutes: Benefits and costs. Burns 2001; 27: vii-viii.
79. Boyce ST. Design principles for composition and performance of cultured skin substitutes. Burns 2001; 27: 523-33.